Authors/Disclosures
|
Jorge C. Kattah, MD, FAAN
(University of Illinois College of Medicine at Peoria)
|
Dr. Kattah has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Bonezzi, Switzer , Poilitto and Hupp Legal Firm. |
|
John Pula, MD, FAAN
(NorthShore University HealthSystem)
|
Dr. Pula has nothing to disclose. |
|
Harold Moses, MD
(Vanderbilt Multiple Sclerosis Center)
|
No disclosure on file |
|
Deepak S. Nair, MD
(OSF HealthCare)
|
Dr. Nair has nothing to disclose. |
|
Michael Levy, MD, PhD, FAAN
(Massachusetts General Hospital/Harvard Medical School)
|
Dr. Levy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi Pharma. Dr. Levy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB Pharma. Dr. Levy has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Levy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Levy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Levy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Levy has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Levy has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Various law firms. The institution of Dr. Levy has received research support from National Institutes Health. |
|
Sarah H. Ying, MD
(MEEI)
|
Dr. Ying has nothing to disclose. |
|
David E. Newman-Toker, MD, PhD, FAAN
(Johns Hopkins Unversity School of Medicine, Dept of Neurology)
|
The institution of Dr. Newman-Toker has received research support from NIH, AHRQ, AHA, Moore Foundation. Dr. Newman-Toker has received intellectual property interests from a discovery or technology relating to health care. |